Xanthophyll: Health benefits and therapeutic insights.


Journal

Life sciences
ISSN: 1879-0631
Titre abrégé: Life Sci
Pays: Netherlands
ID NLM: 0375521

Informations de publication

Date de publication:
01 Jan 2020
Historique:
received: 16 09 2019
revised: 13 11 2019
accepted: 24 11 2019
pubmed: 30 11 2019
medline: 14 1 2020
entrez: 30 11 2019
Statut: ppublish

Résumé

Xanthophylls constitute a major part of carotenoids in nature. They are an oxidized version of carotenoid. Xanthophyll has widely drawn scientists' attentions in terms of its functionality, bioavailability and diversity. An assortment of xanthophyll varieties includes lutein, zeaxanthin, β-cryptoxanthin, capsanthin, astaxanthin, and fucoxanthin. Chemically, lutein and zeaxanthin are dipolar carotenoids with hydroxyl groups at both ends of their molecules that bestow hydrophilic properties to them. Hydrophilic affinity in lutein and zeaxanthin makes better bioavailability in reaction with singlet oxygen in water phase, whereas non-polar carotenoids have shown to have less efficiency in scavenging free radicals. Xanthophylls have been studied for their effects in a wide variety of diseases including neurologic, ophthalmologic, oral, allergic and immune diseases. This review highlights pharmaco-pharmaceutical applications of xanthophylls as well asits drug interactions with beta-carotene. Different types of xanthophylls have been shown to have neuroprotective effects. Fucoxanthin demonstrated potent antiplasmodial activity. Lutein and zeaxanthin prevent the progression of age related macular degeneration. They have also demonstrated promising effects on uveitis, retinitis pigmentosa, scleritis, cataracts, glaucoma, retinal ischemia and choroideremia. Astaxanthin showed to have skin protecting effects against ultraviolet light injury. Astaxanthin have anti-allergic activity against the contact dermatitis especially to treat the patients having adverse reactions induced by steroids. Astaxanthin has been reported to exert beneficial effects in preventing oral lichen planus and early stage cancers. β-cryptoxanthin has been considered a good candidate for prevention of bone loss via osteoblastic bone formation and inhibiting osteoclastic bone resorption. There is also some concern that higher dose of xanthophylls may be linked to increased risk of skin cancer and gastric adenocarcinoma. However this increased risk was not statistically significant when adjusted for confounding factors. Further researches including clinical studies are needed to better evaluate the efficacy and safety of xanthophylls in prevention and treatment of different diseases.

Identifiants

pubmed: 31783054
pii: S0024-3205(19)31031-8
doi: 10.1016/j.lfs.2019.117104
pii:
doi:

Substances chimiques

Neuroprotective Agents 0
Xanthophylls 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

117104

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Ejaz Aziz (E)

Department of Botany, GDC Khanpur, Haripur, Pakistan. Electronic address: ejaz.aziz.qau@gmail.com.

Riffat Batool (R)

University Institute of Biochemistry and Biotechnology, PMAS-UAAR, Rawalpindi, Pakistan. Electronic address: riffatbatoolqau@gmail.com.

Wasim Akhtar (W)

Department of Botany, University of Azad Jammu and Kashmir, Muzaffarabad, Pakistan.

Shazia Rehman (S)

Department of Plant Sciences, Quaid-i-Azam University Islamabad, Pakistan.

Tasmeena Shahzad (T)

Department of Plant Sciences, Quaid-i-Azam University Islamabad, Pakistan.

Ayesha Malik (A)

Department of Plant Sciences, Quaid-i-Azam University Islamabad, Pakistan.

Mohammad Ali Shariati (MA)

Laboratory of Biocontrol and Antimicrobial Resistance, Orel State, University Named After I.S. Turgenev, 302026 Orel, Russia.

Alexey Laishevtcev (A)

Laboratory of Biocontrol and Antimicrobial Resistance, Orel State, University Named After I.S. Turgenev, 302026 Orel, Russia; Federal Research Center - All-Russian Scientific Research Institute of Experimental Veterinary Medicine named after K.I. Skryabin and Y.R. Kovalenko of the Russian Academy of Sciences, Moscow 109428, Russia.

Sergey Plygun (S)

Laboratory of Biocontrol and Antimicrobial Resistance, Orel State, University Named After I.S. Turgenev, 302026 Orel, Russia; European Society of Clinical Microbiology and Infectious Diseases, Basel 4051, Switzerland; All Russian Research Institute of Phytopathology, Moscow Region 143050, Russia.

Mojtaba Heydari (M)

Poostchi Ophthalmology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Abdur Rauf (A)

Department of Chemistry, University of Swabi, Anbar, KPK, Pakistan. Electronic address: mashaljcs@yahoo.com.

Shaheer Ahmed Arif (S)

Bioproducts Sciences and Engineering Laboratory, Washington State University Tricities, 2710, Crimson way, Richland, WA 99354, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH